KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $87,600,000 | -33.9% | 6,000,000 | -14.3% | 1.24% | -52.5% |
| Q2 2020 | $132,580,000 | -1.4% | 7,000,000 | 0.0% | 2.62% | -42.3% |
| Q1 2020 | $134,470,000 | +18.9% | 7,000,000 | +18.6% | 4.54% | +36.7% |
| Q4 2019 | $113,103,000 | +94.3% | 5,900,000 | -2.5% | 3.32% | +36.8% |
| Q3 2019 | $58,201,000 | +673.5% | 6,050,000 | +979.1% | 2.43% | +576.3% |
| Q1 2018 | $7,524,000 | – | 560,658 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 999,275 | $37,403,000 | 55.08% |
| New Leaf Venture Partners, L.L.C. | 126,687 | $4,742,000 | 2.31% |
| Cormorant Asset Management, LP | 385,000 | $14,411,000 | 2.22% |
| SECTORAL ASSET MANAGEMENT INC | 529,920 | $19,835,000 | 0.89% |
| PFM Health Sciences, LP | 850,337 | $31,828,000 | 0.74% |
| Partner Investment Management, L.P. | 16,399 | $614,000 | 0.25% |
| Tekla Capital Management LLC | 137,766 | $5,157,000 | 0.24% |
| Candriam S.C.A. | 298,000 | $11,154,000 | 0.23% |
| Eventide Asset Management | 30,000 | $1,123,000 | 0.12% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 81,047 | $3,034,000 | 0.12% |